Matthew Lehman

Matthew Lehman served as Prima BioMed Ltd.’s Chief Operating Officer since February 2010, prior to becoming the company’s Chief Executive Officer this year. From 2000 until 2010, Mr. Lehman was Chief Operating Officer for SPRI Clinical Trials in the U.S. and Europe, where he managed teams in all areas of clinical operations. Mr. Lehman is based in San Francisco, and plays a key role in leading Prima BioMed Ltd.’s research and development plans, and clinical trials for its CVac ovarian cancer therapy vaccine. Mr. Lehman has a Master of Science from Columbia University in New York, and a Bachelor of Arts from the University of Louisville, Kentucky. He is also a member of the European Business Association and Association for Clinical Research Professionals.